insights_auto
Why is EDIT down 2,41%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,82 US$
arrow_downward
-2,41%(-0,045) 1D
1,85 US$
arrow_upward
+1,37% (+0,025)todayPre-market
Closed: 17 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,90 US$
High
1,94 US$
Low
1,82 US$
Mkt. cap
281,67 მლნ.
Avg. vol.
2,41 მლნ.
Volume
3,35 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,90 US$
High
1,94 US$
Low
1,82 US$
Mkt. cap
281,67 მლნ.
Avg. vol.
2,41 მლნ.
Volume
3,35 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
FOREX.com
·
31 წუთის წინ
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Reuters
·
34 წუთის წინ
UBS sees S&P 500 at 8,200 by end-2027 on earnings strength, resilient economy
BeInCrypto
·
2 საათის წინ
How Deep Do S&P 500 Corrections Usually Go? Where 2026’s Drop Ranks
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc